A Prospective, Non-interventional, Multi-country Cohort Study of the Effectiveness and Safety of Filgotinib in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Latest Information Update: 13 Mar 2025
At a glance
- Drugs Filgotinib (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms GALOCEAN
- Sponsors Galapagos NV
- 16 Aug 2024 Planned End Date changed from 1 Dec 2025 to 1 Dec 2027.
- 16 Aug 2024 Planned primary completion date changed from 1 Dec 2025 to 1 Dec 2027.
- 02 Jun 2023 Planned initiation date changed from 1 May 2023 to 1 Jun 2023.